Provider review · Public-source analysis

Joi + Blokes Review: Quarterly GLP-1 Pricing and Cancellation Terms

Compounded medication plans, a separate Zepbound service fee, conflicting refund language and the June 2026 FDA warning letter.

By Presidential GLP-1 Editorial Team · Published 2026-10-15 · Sources checked 2026-10-15

This is a commercial publication, not a government agency. We did not purchase medication, evaluate patients, test products or audit licenses. No numerical rating is assigned.

Joi + Blokes combines prescription access with clinician consultations and health coaching. Its current compounded GLP-1 landing page advertises semaglutide at $179 per month after a $99 introductory month and tirzepatide at $249 per month after a $149 introductory month, both billed quarterly. Those are different offers from its $99-per-month Zepbound service program, which excludes medication.

The October 15 public-source review found a more consequential comparison than the first-month discount: the landing page invites cancellation at any time, while the general terms require a minimum commitment and advance notice. A separate refund page also conflicts with the landing page’s medical-ineligibility refund statement. Before enrolling, establish the exact plan and the policy that will govern its first charge.

Translate the monthly headline into a quarterly commitment

Published planAdvertised rateIllustrative three-month amount
Compounded semaglutide$99 first month, then $179/month$457 initially; $537 for three full-price months
Compounded tirzepatide$149 first month, then $249/month$647 initially; $747 for three full-price months
Zepbound service program$99/month, medication excluded$297 service fee, plus the separate prescription cost

The compounded-plan totals above are our arithmetic: one introductory month plus two standard months, followed by three standard months. They are not checkout receipts. The landing page and semaglutide product page show quarterly billing, but we did not complete a purchase to verify how the discount is applied, when a renewal is processed or whether any additional checkout charge applies.

The compounded offer says medication, dosing support, clinician consultations and coaching are included. It describes labs as optional rather than required for that offer and advertises no membership fee. Ask whether any optional testing, shipping or outside service adds to the quoted amount. A bundle can still have a recurring commitment even when the company does not call part of the price a membership fee.

The Zepbound program buys services, with medicine paid separately

The Zepbound product page explicitly shows a $297 charge for three months of services. It describes virtual visits, coaching, lab access and continuing support, then directs approved patients to a separate LillyDirect medication purchase. Lab access is not a clear promise that every test is paid for. The drug prices reproduced on that page are the provider’s quoted figures; we have not adopted them as current manufacturer prices.

Joi + Blokes says it can assist with prior authorization and prescription submissions for some insurance-eligible branded products, while not billing insurance directly. Its described cash-pay vial route is separate from that insurance discussion. A prescription, an authorization request and an insurer’s coverage decision are different events. Confirm the route and expected pharmacy charge before comparing the $99 service headline with an offer that includes a compounded medicine.

The cancellation wording needs reconciliation

The September 15, 2025 terms require at least three consecutive months for subscription services. They describe cancellation by emailing info@joiandblokes.com thirty days before the next monthly processing date after the initial commitment. The GLP-1 page instead advertises flexible cancellation, while describing quarterly billing. Ask which processing date applies to that quarterly purchase and whether the general notice rule governs it.

The refund policy makes prescription and lab sales final. Its insurance-backed GLP-1 section says a subscription ends if a patient is not approved, but previously paid subscription fees are not refunded. The compounded landing page’s FAQ instead promises an immediate refund when a prescription is inappropriate. Those statements may concern different products or fees, but the public pages do not reconcile them for an individual order.

Request a written explanation of the treatment-ineligibility outcome before paying: which charge is returned, which is retained and when a refund is processed. Do the same for a change-of-mind cancellation. Neither the words “cancel anytime” nor a lack of shipment establishes that money already paid will be returned. These are published company policies, not a determination of anyone’s legal rights.

Clinicians, coaches and pharmacies have different roles

The landing-page disclosure says Joi + Blokes does not provide medical care itself and instead works with independent third-party clinician groups. The clinical reviewer decides whether a prescription is appropriate. The checked offer does not establish the legal practice or dispensing pharmacy that would be assigned to a particular reader. Ask for both names and their contacts before treating a branded vial illustration as the identity of the compounder.

Coaching is an advertised part of the bundle, but the FAQ explicitly distinguishes coaches from prescribing clinicians. It describes a range of coaching backgrounds and says coaches cannot diagnose, prescribe or provide specific medical advice. Unlimited messaging is a contact feature, not a response time that we measured. Use the clinical channel for prescription questions and ask how coaching and medical follow-up are coordinated.

What FDA said in June 2026

FDA issued warning letter 728283 to Joi and Blokes doing business as Joi + Blokes on June 8, 2026, following a March website review. The agency cited imagery suggesting the company compounded its products and semaglutide claims implying equivalence with approved medicines. FDA said those representations made the products misbranded under the cited provisions. This is an attributed regulatory finding about the reviewed marketing, not our test of a dispensed batch.

The current page says the company does not manufacture the medication and that compounded preparations are not FDA approved. We have not established a closeout or other resolution of the warning letter. A revised disclosure should be read alongside the dated regulatory record; it does not itself prove that the agency considers the matter resolved.

Who can assess this offer with the available information?

A reader who values coaching alongside prescription care can identify the advertised service bundle and model its quarterly cost. The missing step is a written answer about commitment, cancellation timing and medical-ineligibility refunds. We did not test the service, verify pharmacy licenses, audit patient outcomes or assign a numerical score. Provider testimonials and review counts are not independent evidence of clinical results.

  • Save the full quarterly charge, renewal date and discount terms.
  • Identify the clinical group and pharmacy for the actual order.
  • Resolve the thirty-day notice rule against the cancellation headline.
  • Confirm whether an eligibility decision refunds the medication charge, service fee or both.

Compare the kit-based approach in our Nuform Health review, then use the pricing-model guide to keep medication, care fees and prepaid commitments separate. For clinical context, the brand-versus-compounded explainer describes why a lower-cost preparation is not automatically interchangeable with a named FDA-approved product.

Sources and limits

Public pages checked October 15, 2026. Provider pages support descriptions of offers and policies. FDA sources support regulatory context; neither establishes a personal treatment recommendation. Advertised figures may differ at checkout.

  1. Joi + Blokes current compounded GLP-1 offer
  2. Joi + Blokes semaglutide product page
  3. Joi + Blokes Zepbound service program
  4. Joi + Blokes terms, September 15, 2025
  5. Joi + Blokes refund and return policy
  6. Joi + Blokes company description
  7. FDA warning letter, June 8, 2026
  8. FDA concerns about unapproved GLP-1 drugs

Keep comparing